Next |
home / stock / halo / halo message board
Subject | By | Source | When |
---|---|---|---|
Addendum: Should the temptation arise, kindly forgo enlightening me | easycomeandgo | investorshub | 04/30/2023 2:11:01 PM |
It is high time for me to (do | easycomeandgo | investorshub | 04/30/2023 1:57:44 PM |
I am not sure what it will take | easycomeandgo | investorshub | 04/28/2023 2:20:54 PM |
By the way, it was the last CFO | Fred Kadiddlehopper | investorshub | 04/28/2023 1:49:36 PM |
Yes, the efgartigimod delay was noted here; not | Fred Kadiddlehopper | investorshub | 04/28/2023 1:44:49 PM |
Agree. Just saw an article by a reporter for | OncoJock | investorshub | 04/28/2023 1:24:33 PM |
Agree with you Maumar about how well this | OncoJock | investorshub | 04/28/2023 1:13:35 PM |
The deal offers no immediate prospects for future | Fred Kadiddlehopper | investorshub | 04/28/2023 12:47:11 PM |
Glad to hear I'm not the only one | OncoJock | investorshub | 04/28/2023 12:41:11 PM |
This is interesting, thanks for posting. | OncoJock | investorshub | 04/28/2023 12:34:34 PM |
argenx and Genmab Enter Partnership to Advance Antibody | Fred Kadiddlehopper | investorshub | 04/17/2023 1:45:00 PM |
Got it. Thanks so much. My | halofan | investorshub | 04/15/2023 1:05:38 AM |
Page 29 on the March Corporate presentation: One ENHANZE One | biotechinvestor1 | investorshub | 04/15/2023 12:31:00 AM |
I looked back at the PR for the | halofan | investorshub | 04/14/2023 11:45:21 PM |
Right, the option activity is nil but I'm | Fred Kadiddlehopper | investorshub | 04/13/2023 9:02:44 PM |
Today the xbi is up almost 5% and | maumar | investorshub | 04/13/2023 7:37:01 PM |
As you could suppose, I am defensive. As | easycomeandgo | investorshub | 04/13/2023 6:34:51 PM |
What else are you looking at in regard | Fred Kadiddlehopper | investorshub | 04/13/2023 2:05:37 AM |
I fear I did not answer your question. | easycomeandgo | investorshub | 04/12/2023 7:40:00 PM |
Fine, no problem. You are not going to | easycomeandgo | investorshub | 04/12/2023 5:17:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Halozyme Therapeutics Inc. Company Name:
HALO Stock Symbol:
NASDAQ Market:
Halozyme Therapeutics Inc. Website:
HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS PR Newswire Revenue Increased 21% YOY to $196 million ; Net Income of $77 million ; Adjusted EBITDA of $116 million ; GAAP Diluted EPS of $0.60 and Non-GAAP Diluted EPS of $0.79 1 ...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...